Concepedia

Dewei She

DS

30

Publications

3.9K

Citations

22

H-Index

2003

Active since

Affiliations

University of Colorado Anschutz Medical Campus(Current)

University of California, San Francisco

Heinrich Heine University Düsseldorf

Horizon Therapeutics (United States)

Charité - Universitätsmedizin Berlin

Dewei She is an author at University of Colorado Anschutz Medical Campus specializing in medicine, pharmacotherapy, and pulmonary disease.

Top concepts

Publications per year

2003–2024

30

Publications

30

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial

Bruce Cree, Jeffrey L. Bennett, Ho Jin Kim et al. · The Lancet · 2019 · 679 citations

, , +5

Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Saskatchewan Canada

Suellen M. Curkendall, Cynthia deLuise, Judith K. Jones et al. · Annals of Epidemiology · 2005 · 605 citations

, , +5

A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma

Edward Piper, Christopher E. Brightling, Robert Niven et al. · European Respiratory Journal · 2012 · 370 citations · Full text

Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial

Christopher E. Brightling, Pascal Chanez, Richard Leigh et al. · The Lancet Respiratory Medicine · 2015 · 363 citations

, , +7

Tezepelumab, an anti–thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial

Eric L. Simpson, Jane R. Parnes, Dewei She et al. · Journal of the American Academy of Dermatology · 2018 · 312 citations · Full text

Rows per page

1–5 of 30